Protocol First

Protocol First, founded in 2015, is revolutionizing the clinical trial industry with its innovative EDC/CDMS platform. By prioritizing the Protocol as the foundation of clinical trials, the company's cutting-edge technology enhances efficiencies throughout the trial process. The platform, tailored for the pharmaceutical industry, is designed to handle protocols of varying complexities, catering to the real-time, collaborative needs of all users. Distinctively, Protocol First is the first EDC platform focused on efficiently collecting response data and identifying safety signals, initially targeting intricate oncology trials with the potential to scale for any clinical trial design. The comprehensive platform also offers adaptability, scalability, and cost savings, making it suitable for trials of any size. Moving forward, with its focus on harnessing simplicity to master any clinical trial design, Protocol First is poised to make research more efficient, intuitive, and collaborative in real-time, representing a promising opportunity for venture capital consideration.